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Abstract
Background: Empirical evidence suggests that prenatal growth is associated with attention deficit/hyperactivity
disorder (ADHD) and its symptoms. Data on the importance of postnatal growth is, however scanty. We studied
whether pre- and postnatal growth up to 56 months is associated with symptoms of ADHD in children.
Method: A longitudinal regional birth cohort study comprising 893 children followed up to 56 months. The
associations between pre- and postnatal growth and parent-rated ADHD symptoms of the child were analyzed
with multiple linear regression analyses and repeated-measures analyzes of covariance.
Results: Children born lighter, thinner, shorter, and with a smaller head circumference, adjusted for length of
gestation, received higher parent-rated ADHD symptoms scores at 56 months. Further, smaller head circumference
throughout the period of growth from birth up to 56 months was related to higher ADHD symptoms scores. The
associations changed only little after adjusting for several pre- and neonatal factors. The associations were not
modified by sex and there were no evidence of non-linear associations.
Conclusions: Slower prenatal growth in weight, body-mass index, length, and head circumference may pose a risk
for higher ADHD symptoms in childhood. The consistently smaller head circumference from birth up to 56 months
characterizing children with higher ADHD symptoms may point to a lack of catch-up growth in head
circumference in childhood as a predisposing factor.
Background
Attention deficit/hyperactivity disorder (ADHD) is
among the most common neuropsychiatric disorders in
childhood with a worldwide prevalence rate of approxi-
mately 5% [1]. Behavioral symptoms characterizing
ADHD are even more common, and include inattention,
hyperactivity, and impulsiveness [2]. The etiology of
ADHD is multifaceted. Together with genetic and envir-
onmental factors both pre- and postnatal growth may
influence its development [3,4]. Indeed, mounting
empirical evidence shows that prematurity and small
body size at birth are associated with ADHD and its
symptoms [5-11]. The evidence for the importance of
postnatal growth is, however scanty and often
confounded by stimulant medication used in treating
ADHD symptomatology; stimulant-medication may per
se compromise physical growth. Thus, it remains
unknown if postnatal growth is etiologically associated
with ADHD or is a consequence of the stimulant-medi-
cation [12]
In stimulant-naïve child and adolescent samples, those
who gain higher scores in ADHD symptoms or who ful-
fill the criteria of the disorder have in cross-sectional
studies been shown both to be shorter [13,14] or taller
[15,16], to have higher weight [16] and both to have a
lower [17] or a higher [16,18,19] body-mass index
(BMI). Yet, to our knowledge only two studies to date
have addressed the role of physical growth in ADHD:
the first compared growth of 48 boys with ADHD in
relation to population norms and found a distinct sup-
pression of growth in height from 9 to 14 years, earlier
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onset of adolescent growth spurt and a higher velocity
of growth in that moment [15]. The second study
showed in 87 extremely-low-birth-weight boys and girls
that growth in head circumference between birth and
two years did not predict parent/teacher-rated ADHD at
school-age [20]. The current study will test if growth in
height, weight, BMI and head circumference from birth
up to five, 20, and 56 months of age is associated with
parent-rated ADHD symptoms at 56 months. Thus, the
current study will add new information of the associa-
tion between the postnatal growth from birth to pre-
school-age and symptoms of ADHD in a stimulant-
naïve sample of girls and boys. By using different time
points and a range of anthropometric measurements the
study will also show whether there are particular periods
of growth or measures that are specifically related to
symptoms of ADHD.
Methods
Participants
The study cohort comprised infants participating in the
Arvo Ylppö Longitudinal Study (AYLS) [21,22]. Of a
total of 15,311 deliveries in the seven maternity hospitals
in the county of Uusimaa, Finland, we identified all live-
born infants between March 15, 1985 and March 14,
1986 who were admitted to the neonatal wards of the
obstetric units or transferred to the Neonatal Intensive
Care Unit of the Hospital for Children and Adolescents,
University of Helsinki, within 10 days of birth. The
population ranged from severely ill preterm infants to
infants born at term requiring only brief inpatient obser-
vation. In total, there were 1,535 admitted infants (n =
867 boys). In addition, 658 infants (n = 328 boys), born
during the same period but not admitted to the neonatal
ward, were randomly recruited from the three largest
maternity hospitals in the study area. Participants were
invited to clinical follow-ups at 5 and 20 months of cor-
rected age and at 56 months of age. The study protocol
was approved by the Ethical Committees of Helsinki
City Maternity Hospital, Helsinki University Central
Hospital, and Jorvi Hospital, and the parent(s) gave their
informed consent.
Of the 2,193 infants 2,125 survived to 56 months of
age. We excluded 80 infants with congenital malforma-
tions and chromosomal abnormalities, and Mendelian
disorders potentially affecting growth. At least one birth
size measure, control variable and/or parental ratings of
ADHD at 56 months was lacking for 1,232 children.
Thus, the participants in the present study included 893
children: boys (n = 490) and girls (n = 403). The original
cohort is described in detail elsewhere [22,23].
The study participants (n = 893) did not differ from
those who were lost to follow-up due to lack of infor-
mation on any birth size measure, gestational age and/
or pre- and neonatal control variables (n = 225) in sex,
multiple pregnancy, mother’s height, on BMI at five
months, or in any body size measures at 20 and 56
months (all p-values > .05). However, those lost to fol-
low-up were more likely to have been admitted to a
neonatal ward, to come from less educated families, to
have younger mothers, and mothers who smoked more
during pregnancy. Furthermore, they were lighter,
shorter and had smaller head circumference at birth,
and at 5 months, and were also thinner at birth, born
earlier and less likely to be breast fed (all p-values <
.04). Further, the study participants (n = 893) did not
differ from those who were lost to follow-up due to lack
of information on parental rated ADHD symptoms (n =
927) in any body size or control variables, except that
those who did not had ADHD symptoms scores avail-
able were shorter at 5 and 20 months and their mothers
had smoked more during pregnancy (p-values < .049).
As the ADHD symptoms were measured at the age of
56 months the participants were not yet treated with sti-
mulant medication, even if symptoms of ADHD might
already be present.
Measures
Body size at birth, and in infancy and childhood
Data on the newborns’ date of birth, weight (g), length
(cm) and head circumference (cm) were extracted from
hospital birth records, and BMI was calculated (kg/m2).
The same anthropometric measures were taken during
the clinical visits at five and 20 months of corrected age
and at 56 months.
Growth
The growth variables were the standardized residuals
from the linear regression models where body size at
each time point was regressed on corresponding size
measures at all earlier time points, thus creating com-
pletely uncorrelated residuals reflecting growth condi-
tional on previous history. The residuals provided
information on whether growth by a particular age was
faster or slower than would have been predicted from
previous measurements.
Gestational age
Gestational age was determined from the date of the
mother’s last menstrual period and/or ultrasound exami-
nation. All the infants were given an assessment of clini-
cal maturity [24]. When there was a difference in the
estimates of more than two weeks, gestational age was
corrected according to Dubowitz maturity scale, except
for preterms under 32 weeks of gestational age.
Parental Ratings of ADHD symptoms
At the 56-month follow-up the parents evaluated the
child’s ADHD symptoms with the Conners’ Hyperactiv-
ity Index -parent version [25]. This index is composed
of ten items rated on a four-point scale (0 = not at all
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to 3 = very much). Sample items are: “Inattentive, easily
distracted” and “Restless or overactive”. The items were
summed with higher scores reflecting higher levels of
ADHD symptoms. Cronbach’s alpha was .85.
Potential covariates
We tested if the associations between body size/growth
variables and ADHD symptoms were confounded by the
child’s sex, gestational age, admission to neonatal ward
during the first ten days, multiple pregnancy (singleton
vs. multiple), mother’s smoking during pregnancy (none,
1-10, > 10 cigarettes/day), parental education (four point
scale of highest self-reported level of education of either
parent: from high = university education to low = ele-
mentary school education or less), maternal age (years),
maternal height (cm).
Statistical analysis
Body size at birth and at five, 20, and 56 months of age
was converted into z scores (Mean = 0; Standard Devia-
tion (SD) = 1) by sex, and birth size measures addition-
ally by gestational age. The standardized scores
represent the difference from mean value for the sample
of control children participating in the current study (i.
e. those who were not admitted to neonatal ward).
As the primary data analytical tool, we used multiple
linear regression analysis. We examined, first, if body
size at birth, and at five, 20 and 56 months, and, second,
if growth from birth to five, 20 and 56 months of age,
conditional on previous history, predicted the child’s
ADHD symptoms at 56 months as a continuous score.
As the associations are not necessarily linear, we also
tested the potential non-linearity of the associations by
entering squared terms of body size at each time point
into the regression equation following the linear terms.
Finally, we examined trajectories of growth by using
repeated-measures analysis of covariance (ANCOVA). In
the ANCOVA body size at birth, five, 20 and 56 months
of age represented the within-person dependent vari-
ables, and quintiles of ADHD symptoms at 56 months
represented the independent between-person grouping
variable. All associations were tested after controlling
for the sex of the child, and then further controlling for
pre- and neonatal covariates.
We also re-ran analyzes in a subgroup of children not
admitted to neonatal ward during first 10 days, and who
had birth weight ≥ 2,500 g and were born at term (≥ 37
weeks of gestation). This remaining subgroup included
293 children.
Results
Table 1 shows characteristics of the sample divided by
sex. Compared with girls, boys had higher scores on
ADHD-symptoms at 56 months. Boys were bigger at all
measurement points and were more likely to have been
admitted to a neonatal ward. In addition, we tested
interactional effects of sex by adding an interaction term
‘sex × body size (each anthropometric variable at each
time point in separate models)’ into the regression equa-
tion in addition to the main effects of these two cen-
tered variables in predicting ADHD-symptoms. These
analyses revealed no significant interactions (all p-values
> .13). All the main results are presented in the pooled
sample. When testing for associations between covariate
variables and ADHD-symptoms, we found that after
controlling for the child’s sex, children of younger
mothers, and of parents with a lower educational level
had higher ADHD-symptoms scores (p-values < .002; all
other p-values > .13).
Relative body size and parent-rated ADHD symptoms at
56 months
Table 2 shows that lower weight, shorter length, smaller
head circumference and lower BMI at birth were signifi-
cantly associated with higher ADHD symptoms scores
after controlling for child’s sex. Table 2 also shows that
smaller head circumference at five, 20 and 56 months of
age were significantly associated with higher ADHD
symptoms scores. After controlling for pre- and neona-
tal covariates, the association between head circumfer-
ence at 20 months and ADHD symptoms were rendered
to marginal significance (from p = .02 to p = .08),
whereas the previously marginally significant association
between lower BMI at 56 months and higher ADHD
symptoms became significant (from p = .09 to p = .04).
Growth and parent-rated ADHD symptoms at 56 months
Growth conditional on history
After controlling for child’s sex there were no significant
associations between growth (conditional on history)
and ADHD symptoms. However, after controlling for
the rest of the covariates the previously marginally sig-
nificant association (p = 0.06) between a slower gain in
BMI from 20 to 56 months and higher ADHD symp-
toms scores became significant (B = -0.37, 95% Confi-
dence Interval (CI): -0.70 to -0.32, p = .03) (Table 3.).
Growth trajectories
Figure 1 displays the growth trajectory of head circum-
ference in quintiles of ADHD symptoms scores in a
fully controlled model. The pattern of the growth trajec-
tory across time was not significantly different between
the ADHD symptoms group (ADHD grouping × time, p
= .93). However, children who had ADHD symptoms
scores in the highest quintile displayed the lowest head
circumference and children having the lowest ADHD
symptoms scores displayed the highest head circumfer-
ence from birth to 56 months (Mean difference in SD
units = 0.27, 95% CI = 0.06 to 0.49, p = .01). Head cir-
cumferences of the children with ADHD symptoms
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scores in the middle three quintiles fell between these
two extreme quintiles. The analyses of other growth
measures by quintiles of ADHD symptoms were not sta-
tistically significant.
Associations in a subgroup of full term and normal birth
weight children not admitted to neonatal ward
Finally, we tested whether the observed results remained
similar in a subgroup of children who were not admitted
to the neonatal ward, had birth weight ≥ 2,500 g and
were born at term (≥ 37 weeks of gestation) (n = 293).
We found that in a fully controlled model lower weight
(p = 0.005), smaller head circumference (p = 0.06) and
lower BMI (p = 0.001) at birth were significantly or
marginally significantly associated with higher ADHD
symptoms scores. However, birth length was not asso-
ciated with the ADHD symptoms (p = 0.27). Further,
smaller head circumference at five (p = 0.05), 20 (p =
Table 1 Characteristics of the sample by sex
Boys Girls
n Mean (SD)/n (%) n Mean (SD)/n (%)
Parental rated ADHD-symptoms 490 9.5 5.0 403 8.4 4.7 *
Body size
At birth
Weight, kg 490 3.4 0.8 403 3.3 0.7 *
Length, cm 490 49.6 3.6 403 48.7 3.2 *
Head circumference, cm 490 35.0 2.2 403 34.3 2.1 *
BMI, kg/m2 490 13.5 1.8 403 13.5 1.8
At 5 months
Weight, kg 482 7.6 0.9 394 7.0 0.9 *
Length, cm 478 66.5 2.3 388 64.5 2.2 *
Head circumference, cm 480 43.6 1.2 391 42.3 1.1 *
BMI, kg/m2 476 17.2 1.5 388 16.8 1.5 *
At 20 months
Weight, kg 457 12.1 1.4 376 11.4 1.4 *
Height, cm 444 84.6 3.1 369 83.2 3.2 *
Head circumference, cm 459 49.4 1.4 381 48.1 1.2 *
BMI, kg/m2 440 16.8 1.4 369 16.4 1.3 *
At 56 months
Weight, kg 482 18.5 2.6 393 17.8 2.7 *
Height, cm 470 108.6 4.4 390 107.3 4.6 *
Head circumference, cm 476 52.3 1.5 392 51.0 1.3 *
BMI, kg/m2 469 15.6 1.5 387 15.4 1.5 *
Covariates
Gestational age, weeks 490 38.4 2.8 403 38.7 2.6
Admission to neonatal ward (n, %) 490 341 69.6 403 251 62.3 *
Multiple pregnancy (n, %) 490 21 4.3 403 21 5.2
Maternal smoking during pregnancy (n, %) 490 403
> 10 cigarettes/day 27 5.5 25 6.2
1-10 cigarettes/day 82 16.7 71 17.6
None 381 77.8 307 76.2
Mother’s
Height, cm 490 164.4 5.4 403 164.3 5.5
Age, Years 490 29.4 5.1 403 29.4 5.0
Parental education (n, %) 490 403
I 58 11.8 48 11.9
II 171 34.9 154 38.2
III 151 30.8 107 26.6
IV 110 22.4 94 23.3
Breast fed (yes: n, %) 490 457 93.3 403 378 93.8
Note. ADHD = Attention-Deficit/Hyperactivity Disorder, BMI = Body-mass index, Parental education I = Low to IV = High, * P < 0.05.
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Table 2 Relative body size at birth, and up to 56 months of age and ADHD-symptoms
Model I Model II
Effect size in SD units (95% CI) P-value Effect size in SD units (95% CI) P-value
At birth
Weight -0.39 (-0.65 to -0.13) 0.003 -0.41 (-0.69 to -0.14) 0.003
Length -0.32 (-0.58 to -0.06) 0.02 -0.33 (-0.61 to -0.05) 0.02
Head circumference -0.40 (-0.68 to -0.12) 0.01 -0.36 (-0.65 to -0.07) 0.01
BMI -0.33 (-0.59 to -0.07) 0.01 -0.33 (-0.60 to -0.06) 0.02
At 5 months
Weight -0.16 (-0.45 to 0.13) 0.28 -0.19 (-0.53 to 0.15) 0.27
Length -0.12 (-0.42 to 0.18) 0.44 -0.1 (0.46 to 0.26) 0.57
Head circumference -0.39 (-0.69 to -0.10) 0.01 -0.31 (-0.61 to -0.01) 0.04
BMI -0.13 (-0.43 to 0.16) 0.37 -0.17 (-0.50 to 0.15) 0.29
At 20 months
Weight -0.11 (-0.43 to 0.21) 0.49 -0.13 (-0.46 to 0.20) 0.44
Length -0.05 (-0.36 to 0.26) 0.73 -0.02 (-0.35 to 0.31) 0.90
Head circumference -0.36 (-0.68 to -0.05) 0.02 -0.29 (-0.61 to 0.04) 0.08
BMI -0.14 (-0.46 to 0.19) 0.42 -0.19 (-0.52 to 0.14) 0.26
At 56 months
Weight -0.04 (-0.36 to 0.25) 0.72 -0.1 (-0.43 to 0.24) 0.57
Length 0.09 (-0.22 to 0.40) 0.56 0.15 (-0.20 to 0.51) 0.40
Head circumference -0.40 (-0.71 to -0.10) 0.01 -0.34 (-0.65 to -0.03) 0.03
BMI -0.27 (-0.57 to 0.04) 0.09 -0.34 (-0.67 to -0.01) 0.04
ADHD = Attention-Deficit/Hyperactivity Disorder, BMI = Body-mass index
Model I: After controlling for child’s sex; Model II: after controlling for child’s sex, gestational age, admission to neonatal ward, multiple pregnancy, mother’s
smoking during pregnancy, parental education, maternal age, and maternal height.
Table 3 Associations between growth (conditional on history) and parental rated symptoms of Attention deficit/
hyperactivity disorder (ADHD)
Growth variable Parental rated symptoms of ADHD, Unstandardized regression coefficient (95% CI)
Model I Model II
Weight
At birth -0.37 (-0.64 to -0.09)* -0.37 (-0.66 to -0.08)*
Growth from birth to 5 months 0.02 (-0.33 to 0.37) -0.01 (-0.36 to 0.34)
Growth from 5 to 20 months 0.11 (-0.22 to 0.43) 0.09 (-0.24 to 0.41)
Growth from 20 to 56 months -0.03 (-0.36 to 0.30) -0.09 (-0.42 to 0.24)
Length/height
At birth -0.29 (-0.56 to -0.01)* -0.28 (-0.57 to 0.02)
Growth from birth to 5 months 0.12 (-0.24 to 0.49) 0.12 (-0.25 to 0.48)
Growth from 5 to 20 months 0.03 (-0.29 to 0.36) 0.06 (-0.27 to 0.39)
Growth from 20 to 56 months 0.11 (-0.24 to 0.45) 0.07 (-0.27 to 0.42)
Head circumference
At birth -0.37 (-0.67 to -0.07)* -0.33 (-0.63 to -0.02)*
Growth from birth to 5 months -0.18 (-0.52 to 0.16) -0.15 (-0.49 to 0.20)
Growth from 5 to 20 months -0.23 (-0.58 to 0.12) -0.19 (-0.54 to 0.16)
Growth from 20 to 56 months -0.25 (-0.59 to 0.10) -0.25 (-0.59 to 0.09)
Body-mass-index
At birth -0.22 (-0.50 to 0.05) -0.22 (0.51 to 0.07)*
Growth from birth to 5 months -0.02 (-0.36 to 0.32) -0.08 (-0.41 to 0.27)
Growth from 5 to 20 months 0.07 (-0.27 to 0.41) 0.03 (-0.31 to 0.37)
Growth from 20 to 56 months -0.31 (-0.65 to 0.02) -0.37 (-0.70 to -0.03)*
Birth size, growth rates from birth to 5 months, from 5 to 20 months, and from 20 to 56 months are considered simultaneously. The growth variables are
expressed as standardized residuals of regression of size at each age stage on size at previous age stage(s), that is, growth conditional on history. Model I
includes adjustments for child’s sex; Model II includes adjustments for child’s sex, gestational age, admission to neonatal ward during the first ten days, multiple
pregnancy, mother’s smoking during pregnancy, parental education, maternal age and maternal height. * P < 0.05
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0.04) and 56 months of age (p = 0.03) were associated
with higher ADHD symptoms scores. None of the pre-
viously found associations between relative BMI at 56
months and growth in BMI from 20 to 56 months and
ADHD symptoms were present in this subgroup. Finally,
the growth trajectory of head circumference in quintiles
of ADHD symptoms scores was similar to that found in
a total sample. Children who had ADHD symptoms
scores in the highest quintile displayed the lowest head
circumference and children having the lowest ADHD
symptoms scores displayed the highest head circumfer-
ence from birth to 56 months (Mean difference in SD
units = 0.37, 95% CI = 0.02 to 0.72, p = .04).
Discussion
We found in a sample of 893 Finnish children that those
born lighter in weight, thinner in BMI, shorter in stature
and smaller in head circumference were rated by their
parents as having higher ADHD symptoms scores at 56
months. Further, we found that a smaller head circum-
ference throughout the period of growth from birth to
56 months was related to higher ADHD symptoms. We
also found that a slower gain in BMI from 20 to 56
months and a lower relative BMI at 56 months was
associated with higher ADHD symptoms. Controlling
for several pre- and neonatal covariates had little effect
on the results. The associations were not modified by
sex and there were no non-linear associations.
We also found a similar pattern of findings in a sub-
group of term (≥ 37 weeks of gestation), normal birth
weight (≥ 2,500 g) children not admitted to neonatal
ward (n = 293) with three clear exceptions: the associa-
tion between birth length, growth in BMI from 20 to 56
months and the relative BMI at 56 months and ADHD
symptoms scores were turned to non-significant.
There are several strengths in this study. We were
able to examine the early childhood growth using multi-
ple anthropometric variables in a prospective study
Figure 1 Head circumference up to 56 months of age and Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms. The associations
between head circumference (Standard Deviation (SD) scores) at birth, and at five, 20 and 56 months age and parent rated ADHD symptoms as
quintiles after controlling for child’s sex, gestational age, admission to neonatal ward, multiple pregnancy, mother’s smoking during pregnancy,
parental education, maternal age, and maternal height.
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design. Most of the existing studies have been con-
ducted with data derived from clinical practice, which
may favor a higher than expected rate of positive find-
ings [26]. Also studies with stimulant-naïve sample are
needed to evaluate whether potential growth deficits
may indeed be etiologically related to ADHD and not a
consequence of stimulant-medication used to treat
symptomatology [12]. Further, we had the whole birth
weight range available and could control for several vari-
ables that may have an impact on growth and/or ADHD
symptoms. Controlling for covariates increases the likeli-
hood that the findings are true and not due any con-
founding factor related to the both independent and
dependent variables. We could also exclude children
with severe conditions that could have potentially con-
founded the findings.
There are also some limitations. For practical reasons,
several parents did not receive or fill in the ADHD
questionnaire. However, those who did and did not
receive/fill in the questionnaire did not differ from each
other in most of the measured variables. However, com-
pared to those lost to follow-up the participants were
taller at five and at 20 months, and their mothers
smoked less during pregnancy. Therefore, the results
may be more characteristic of children exposed to less
adverse pre- and postnatal environments. Further, we
had no information on the parental ADHD symptoms
and were, thus, unable to take potential genetic suscept-
ibility into account. Neither, did we have information on
environmental postnatal factors as non-optimal parent-
ing [27,28] and family adversity [29] that have been
shown to be related to symptoms of ADHD. However,
we have controlled for parental education, which is a
crude proxy of several environmental adversities. As we
have used multiple measures of body size at four differ-
ent time points, we have ended up making multiple
tests. However, we decided not to use the correction for
multiple testing (e.g., Bonferroni correction). First, as
the number of Type I errors cannot decrease without
increasing type II errors [30]. Second, theoretical
assumption behind the correction of multiple testing is
that all null hypotheses are true simultaneously, which
was not of interest of our study. It is suggested simply
describing carefully the used analyses is usually the most
rational way of dealing with multiple testing [31].
We have previously shown with the same data that
small for gestational age (SGA) status, rather than pre-
maturity per se, may increase risk for symptoms of
ADHD in young children [9]. While current findings
showing associations between smaller body size in
weight, length, head circumference and BMI at birth
and higher ADHD symptoms scores are in accordance
with our and majority of others previous findings
[5-8,10,11], they also extend them in significant ways.
Of the few previous studies focusing on children born
across the whole gestational age/birth weight range [e.g.,
[9,32]] to our knowledge none has focused on birth
weight, length, head circumference and BMI in a same
study. In our cohort, birth weight and head circumfer-
ence seem to have the strongest associations with parent
rated ADHD symptoms.
With regard to postnatal growth, to our knowledge
there are only three prior studies focusing on postnatal
head circumference and ADHD or its symptoms. Ptcak
et al. [33] suggested that 4-16 years-old boys with diag-
nosed ADHD have a smaller head circumference than
the normal non-clinical population, although the asso-
ciation was only marginally significant among those
boys who did not receive medication (n = 52, p = .07).
Hack et al. [34] found among 249 very-low-birth-weight
children that those who had a subnormal head size (less
than the mean -2 SD for age) at 8 months of corrected
age had a higher incidence of hyperactivity at 8-9 years.
This association became, however, non-significant after
controlling pre- and neonatal covariates. Finally, Stathis
et al. [20] failed to find any significant associations
among 87 extremely-low-birth weight born children
between subnormal head circumference (comparison to
norm z-scores) or head growth velocity from birth to 2
years and parent/teacher rated ADHD diagnoses at
school-age. Because of differences in age of the samples
and periods of growth, direct comparison of our results
showing an association between a smaller head circum-
ference throughout the period of growth from birth to
56 months with higher levels of ADHD symptoms at 56
months, with earlier findings is not possible. The cur-
rent study is the only one that presents results in a rela-
tively large cohort of children born across the whole
birth weight range.
The mechanisms explaining the association between
postnatal head circumference and ADHD symptoms
remain speculative. Head circumference has been shown
to correlate highly with total brain volume (from 1.7 to
six years r = .93) [35]. Smaller total brain volume, in
turn, has been shown to be related to ADHD in several
studies [36]. Further, our results showing that those hav-
ing the highest levels of parent rated ADHD symptoms
were those who had the smaller head circumferences
already at birth and had a persistently smallest head cir-
cumference across the early childhood pointing, at least
partly, to the compromised prenatal period the effects of
which the postnatal growth has not been able to correct.
The longitudinal growth curves of total brain volumes
have been shown to be roughly parallel, although at dif-
ferent levels, between patients with ADHD and healthy
controls [37] suggesting that developmental processes
are essentially healthy in ADHD, and that ADHD symp-
toms appear to reflect fixed earlier neurobiological
Heinonen et al. BMC Pediatrics 2011, 11:84
http://www.biomedcentral.com/1471-2431/11/84
Page 7 of 9
insults or abnormalities. Another study [38] provided
evidence that the pattern of brain maturation in ADHD
was delayed, rather than abnormal. As the brain volume
usually reaches its maximum volume by early adoles-
cence [39] the age range of the participants in the cur-
rent study does not allow conclusions whether the
association between smaller head circumference and
higher levels of ADHD symptoms reflect slow matura-
tion that will disappear later.
We also found that lower relative BMI at 56 months
and slower gain in BMI from 20 to 56 months was
related to higher ADHD symptoms. Earlier studies have
shown that ADHD or its symptoms are associated with
higher BMI [16,18,19] rather than with thinness [17], or
have not found associations with BMI [14,40,41]. All
previous studies have, however, studied older partici-
pants or used diagnoses of ADHD. It should also be
noted that our results became non-significant after
excluding the participants who were admitted to neona-
tal ward during first ten days, were born preterm or had
a birth weight < 2,500 g suggesting the stronger rela-
tionship among those born with compromised prenatal
period or early health problems. However, our findings
of slower gain in BMI may also reflect the measurement
period from 20 to 56 months. At that time children
start to move more by themselves. They may burn a lot
of energy while hyperactive, but the ADHD-related
abnormal eating behaviors (e.g. binge eating) that are
present in older individuals may only have a minor role
on the choices and amount of food consumed see [42].
Earlier studies on height and ADHD have been mainly
cross-sectional and inconsistent in their findings
[13-16,43]. The one existing longitudinal study focusing
on growth in height among 48 ADHD diagnosed boys
from two to 17 years of age found a distinct suppression
of growth in height from nine to 14 years, earlier onset of
adolescent growth spurt and a higher velocity of growth in
that moment [15]. That study however differed from the
current study in measurement of ADHD and in age range.
Our longitudinal findings that parental rated ADHD
symptoms at 56-months are not related to relative height
at successive time points or to growth trajectories during
the first years extend the knowledge of prior studies to
years before ADHD-diagnoses are usually made.
Conclusions
In summary, the results point to the importance of a
slower prenatal growth. The consistently smaller head
circumference from birth to 56 months characterizing
children with higher ADHD symptoms scores may point
to the importance of a lack of catch-up growth in head
in childhood as another predisposing factor. However, it
should be kept in mind that the associations we found
were relatively modest in effect size. Measurements of
body size are nevertheless crude measurements of envir-
onmental conditions early in life, and any association
may give a hint of a biologically significant relationship.
Further, studies are clearly needed to illuminate the
association between growth and ADHD throughout the
entire period of growth.
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